These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2954833)

  • 21. Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum.
    Henselmans JM; Stoof JC
    Brain Res; 1991 Dec; 566(1-2):1-7. PubMed ID: 1687661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine receptors labelled by [3H]quinpirole.
    Seeman P; Schaus JM
    Eur J Pharmacol; 1991 Oct; 203(1):105-9. PubMed ID: 1686763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.
    Geurts M; Hermans E; Cumps J; Maloteaux JM
    Brain Res; 1999 Sep; 841(1-2):135-42. PubMed ID: 10546996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
    Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M
    Eur J Pharmacol; 1994 Jan; 252(1):99-104. PubMed ID: 7908646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
    Ashby CR; Hitzemann R; Rubinstein JE; Wang RY
    Brain Res; 1989 Jul; 493(1):194-7. PubMed ID: 2570618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of apomorphine and pergolide on the potassium-evoked overflow of GABA in rat striatum studied by microdialysis.
    Tossman U; Ungerstedt U
    Eur J Pharmacol; 1986 Apr; 123(2):295-8. PubMed ID: 3709666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.
    Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1988 May; 37(10):2077-84. PubMed ID: 2967702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of dopaminergic receptors in quinolinate-induced striatal lesions.
    Wahl F; Plotkine M; Boulu R; Obrenovitch T; Symon L
    Neuroreport; 1993 Nov; 5(2):151-3. PubMed ID: 7906558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D; Salah RS; Galloway MP
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
    Yamada S; Yokoo H; Nishi S
    Brain Res; 1994 Jun; 648(1):176-9. PubMed ID: 7922522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Eur J Pharmacol; 1987 Jul; 139(3):363-4. PubMed ID: 3666014
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
    Hashimoto T; Katsura M; Kuriyama K
    Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of a dopamine autoreceptor selective profile of B-HT 920 in functional in vitro model systems of D2 receptors in rat striatum.
    Drukarch B; Schepens E; Dolleman-Van der Weel MJ; De Boer P; Van Vliet BJ; Stoof JC
    Eur J Pharmacol; 1990 Oct; 187(2):257-69. PubMed ID: 1980248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LY141865, a D2-dopamine agonist, increases acetylcholine concentration in rat corpus striatum.
    Wong DT; Bymaster FP
    J Pharm Pharmacol; 1983 May; 35(5):328-9. PubMed ID: 6134807
    [No Abstract]   [Full Text] [Related]  

  • 40. Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum.
    Bannon MJ; Kelland M; Chiodo LA
    J Neurochem; 1989 Mar; 52(3):859-62. PubMed ID: 2521894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.